Liang Zhou

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Induced Apoptosis

Endoplasmic Reticulum Stress

Top Venues

Hematology reports

Molecular cancer research : MCR

Clinical cancer research : an official journal of the American Association for Cancer Research

Cellular oncology (Dordrecht)

This page only lists publications with an associated author ORCID identifier.

Publications

Toshihisa Satta, Lin Li, Sri Lakshmi Chalasani, Xiaoyan Hu, Jewel Nkwocha, Kanika Sharma, Maciej Kmieciak, Mohamed Rahmani, Liang Zhou, Steven Grant
Dual mTORC1/2 inhibition synergistically enhances AML cell death in combination with the BCL2 antagonist venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Xiaoyan Hu, Lin Li, Jewel Nkwocha, Kanika Sharma, Liang Zhou, Steven Grant
Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells. Hematology reports 15 (1) (2023)
Lin Li, Xiaoyan Hu, Jewel Nkwocha, Kanika Sharma, Maciej Kmieciak, Hashim Mann, Liang Zhou, Steven Grant
Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells. Cellular oncology (Dordrecht) (2023)
Xiaoyan Hu, Lin Li, Jewel Nkwocha, Kanika Sharma, Liang Zhou, Steven Grant
Synergistic Interactions between the Hypomethylating Agent Thio-Deoxycytidine and Venetoclax in Myelodysplastic Syndrome Cells. Hematology reports 15 (1) (2023)
Liang Zhou, Xinyan Pei, Yu Zhang, Yanxia Ning, Lin Li, Xiaoyan Hu, Sri Lakshmi Chalasani, Kanika Sharma, Jewel Nkwocha, Jonathan Yu, Dipankar Bandyopadhyay, Said M Sebti, Steven Grant
Chk1 inhibition potently blocks STAT3 tyrosine705 phosphorylation, DNA binding activity, and activation of downstream targets in human multiple myeloma cells. Molecular cancer research : MCR (2021)
Liang Zhou, Yu Zhang, Mark B Meads, Yun Dai, Yanxia Ning, Xiaoyan Hu, Lin Li, Kanika Sharma, Jewel Nkwocha, Rebecca E Parker, Danny Bui, Jacquelyn McCarter, Lora Kramer, Cullen Purcell, Praneeth Reddy Sudalagunta, Rafael Renatino Canevarolo, Maria D Coelho Siqueira Silva, Gabriel De Avila, Raghunandan Reddy Alugubelli, Ariosto S Silva, Maciej Kmeiciak, Andrea Ferreira-Gonzalez, Kenneth H Shain, Steven Grant
IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB- and caspase-8-dependent mechanisms. Blood advances 5 (19) (2021)